Promising investigational therapy improves survival in aggressive childhood brain tumor
- OPACC
- Dec 4, 2023
- 1 min read
An international team of investigators has identified a drug candidate that nearly doubles survival rates for patients with diffuse midline glioma, an aggressive type of childhood brain tumor.
Comments